Breaking News Instant updates and real-time market news.

ZYME

Zymeworks

$18.93 /

+0.665 (+3.64%)

18:05
12/08/21
12/08
18:05
12/08/21
18:05

Zymeworks' zanidatamab presents antitumor activity in breast cancer patients

Zymeworks announced new clinical data for the HER2-targeted bispecific antibody, zanidatamab, in heavily pretreated HER2-positive breast cancer. The data are being presented at the San Antonio Breast Cancer Symposium taking place December 7-10. In addition, Zymeworks will present a Trial in Progress poster detailing the ongoing clinical trial evaluating zanidatamab in combination with the CD47-blocker, evorpacept. The data presented at SABCS are from a clinical study of 24 patients with heavily pretreated HER2-positive metastatic breast cancer who received zanidatamab in combination with either vinorelbine - n=12 -, capecitabine - n=8 -, or paclitaxel - n=4 -. In 22 efficacy-evaluable patients, treatment with zanidatamab and chemotherapy resulted in a cORR of 36.4% and DCR of 86.4%, and the majority of patients experienced a decrease in their tumor size. The mPFS is 7.3 months across all treatment regimens with 42% of patients still on study at the time of data cutoff. Zanidatamab in combination with single agent chemotherapy is well tolerated, with the majority of treatment-related adverse events considered mild to moderate in severity. Zanidatamab is also being evaluated in several Phase 2 clinical trials for HER2 expressing gastroesophageal, colorectal, and breast cancers. The FDA has granted zanidatamab with Breakthrough Therapy designation as well as two Fast Track designations. These designations mean zanidatamab is eligible for Accelerated Approval, Priority Review and Rolling Review. Zanidatamab has also received Orphan Drug designations from the FDA as well as the European Medicines Agency for the treatment of biliary tract and gastric cancers.

OTHER BREAKING NEWS FROM THE FLY

Upgrade
FirstService upgraded to Outperform from Market Perform at Raymond James » 07:48
01/24/22
01/24
07:48
01/24/22
07:48
FSV

FirstService

$155.11 /

-4.25 (-2.67%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSV FirstService
$155.11 /

-4.25 (-2.67%)

FSV FirstService
$155.11 /

-4.25 (-2.67%)

04/28/21 Raymond James
Raymond James downgrades FirstService to Market Perform on 'healthy valuation'
04/28/21 Raymond James
FirstService downgraded to Market Perform from Outperform at Raymond James
04/28/21
Fly Intel: Top five analyst downgrades
04/28/21 TD Securities
FirstService downgraded to Hold from Buy at TD Securities
FSV FirstService
$155.11 /

-4.25 (-2.67%)

Hot Stocks
Axalta Coating names Keith Silverman to lead Operations and Supply Chain » 07:48
01/24/22
01/24
07:48
01/24/22
07:48
AXTA

Axalta Coating

$30.30 /

-0.195 (-0.64%)

Axalta Coating appointed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

10/12/21 Mizuho
Axalta Coating initiated with a Buy at Mizuho
09/30/21 Deutsche Bank
Deutsche sees earnings risk for PPG, Axalta after Sherwin-Williams cut
09/21/21 RBC Capital
Axalta Coating price target lowered to $36 from $38 at RBC Capital
09/15/21 BofA
Axalta Coating removed from US 1 List at BofA
AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

Recommendations
Stifel recommends buying Papa John's shares at current levels » 07:48
01/24/22
01/24
07:48
01/24/22
07:48
PZZA

Papa John's

$114.48 /

-0.21 (-0.18%)

Stifel analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

01/07/22 Oppenheimer
Chipotle upgraded to Outperform at Oppenheimer with stock down 17% from high
01/07/22 Stephens
Stephens says Papa John's China deal may be 'meaningful addition' to unit growth
11/12/21 Benchmark
Papa John's initiated with a Buy at Benchmark
11/05/21
Fly Intel: Top five analyst downgrades
PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

  • 20
    Aug
PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

Recommendations
Carvana price target lowered to $165 from $260 at JPMorgan » 07:47
01/24/22
01/24
07:47
01/24/22
07:47
CVNA

Carvana

$135.65 /

-22.12 (-14.02%)

JPMorgan analyst Rajat…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

07:17 Today Morgan Stanley
Carvana pullback presents 'highly compelling' risk/reward, says Morgan Stanley
01/21/22 Wedbush
Carvana price target lowered to $185 from $300 at Wedbush
01/20/22 KeyBanc
KeyBanc more cautious on Carvana, downgrades to Sector Weight
01/20/22 KeyBanc
Carvana downgraded to Sector Weight from Overweight at KeyBanc
CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

Upgrade
Colliers International upgraded to Strong Buy from Outperform at Raymond James » 07:46
01/24/22
01/24
07:46
01/24/22
07:46
CIGI

Colliers International

$137.64 /

-2.25 (-1.61%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIGI Colliers International
$137.64 /

-2.25 (-1.61%)

CIGI Colliers International
$137.64 /

-2.25 (-1.61%)

12/13/21 National Bank
Colliers International initiated with an Outperform at National Bank
10/26/21 RBC Capital
Colliers International price target raised to $185 from $160 at RBC Capital
10/14/21 Scotiabank
Colliers price target raised to $165 from $152 at Scotiabank
02/16/21 TD Securities
Colliers International price target raised to $125 from $100 at TD Securities
CIGI Colliers International
$137.64 /

-2.25 (-1.61%)

Recommendations
VF Corp. price target lowered to $80 from $90 at JPMorgan » 07:45
01/24/22
01/24
07:45
01/24/22
07:45
VFC

VF Corp.

/

+

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
/

+

VFC VF Corp.
/

+

01/20/22 Goldman Sachs
VF Corp. price target lowered to $68 from $71 at Goldman Sachs
01/20/22 Williams Capital
VF Corp. downgraded to Hold from Buy at Williams Capital
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/18/22 Seaport Global
VF Corp. initiated with a Neutral at Seaport Global
VFC VF Corp.
/

+

VFC VF Corp.
/

+

VFC VF Corp.
/

+

Recommendations
Under Armour price target lowered to $28 from $32 at JPMorgan » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
UAA

Under Armour

$18.77 /

+0.26 (+1.40%)

, UA

Under Armour

$16.08 /

+0.11 (+0.69%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

UAA Under Armour
$18.77 /

+0.26 (+1.40%)

01/21/22 Citi
Under Armour upgraded to Buy from Neutral at Citi
01/19/22 Exane BNP Paribas
Under Armour upgraded to Neutral from Underperform at Exane BNP Paribas
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/18/22 Seaport Global
Under Armour initiated with a Neutral at Seaport Global
UA Under Armour
$16.08 /

+0.11 (+0.69%)

01/21/22 Citi
Under Armour upgraded to Buy from Neutral at Citi
01/19/22 Exane BNP Paribas
Under Armour upgraded to Neutral from Underperform at Exane BNP Paribas
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/17/22 BMO Capital
Under Armour upgraded to Outperform from Market Perform at BMO Capital
UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

Recommendations
Ralph Lauren price target lowered to $120 from $122 at JPMorgan » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
RL

Ralph Lauren

/

+

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RL Ralph Lauren
/

+

RL Ralph Lauren
/

+

01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
12/15/21 Truist
Truist starts Ralph Lauren at Buy, sees stage set for 'healthier growth'
12/15/21 Truist
Ralph Lauren initiated with a Buy at Truist
12/14/21
Fly Intel: Top five analyst downgrades
RL Ralph Lauren
/

+

RL Ralph Lauren
/

+

RL Ralph Lauren
/

+

Upgrade
Stantec upgraded to Strong Buy from Outperform at Raymond James » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
STN

Stantec

$52.08 /

-0.98 (-1.85%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STN Stantec
$52.08 /

-0.98 (-1.85%)

STN Stantec
$52.08 /

-0.98 (-1.85%)

01/05/22 National Bank
Stantec price target raised to C$80 from C$72 at National Bank
11/08/21 Desjardins
Stantec price target raised to C$81 from C$75 at Desjardins
10/25/21 Desjardins
Stantec price target raised to C$75 from C$66 at Desjardins
10/25/21 Stifel
Stantec price target raised to C$79 from C$70 at Stifel
STN Stantec
$52.08 /

-0.98 (-1.85%)

Recommendations
Levi Strauss price target lowered to $31 from $35 at JPMorgan » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
LEVI

Levi Strauss

$21.36 /

+0.07 (+0.33%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

01/14/22 BofA
BofA trims Levi Strauss price to $30 as coverage transferred
01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
01/03/22 Guggenheim
Nike remains a 'Best Idea' at Guggenheim heading into 2022
08/30/21
Fly Intel: Top five analyst initiations
LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

Recommendations
Allbirds price target lowered to $17 from $21 at JPMorgan » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
BIRD

Allbirds

$12.34 /

-1.16 (-8.59%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIRD Allbirds
$12.34 /

-1.16 (-8.59%)

01/06/22 Morgan Stanley
Allbirds upgraded to Overweight from Equal Weight at Morgan Stanley
01/03/22 Guggenheim
Nike remains a 'Best Idea' at Guggenheim heading into 2022
12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
BIRD Allbirds
$12.34 /

-1.16 (-8.59%)

  • 03
    Nov
BIRD Allbirds
$12.34 /

-1.16 (-8.59%)

BIRD Allbirds
$12.34 /

-1.16 (-8.59%)

Hot Stocks
Crypto stocks down sharply pre-market as bitcoin falls to six-month lows » 07:43
01/24/22
01/24
07:43
01/24/22
07:43
BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

, COIN

Coinbase

$192.00 /

-29.5 (-13.32%)

, MARA

Marathon Digital

$22.05 /

-2.69 (-10.87%)

, RIOT

Riot Blockchain

$15.00 /

-2.485 (-14.22%)

, BTBT

Bit Digital

$4.65 /

-0.5 (-9.71%)

The price of bitcoin has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTC Bitcoin
/

+

$BTC Bitcoin
/

+

COIN Coinbase
$192.00 /

-29.5 (-13.32%)

MARA Marathon Digital
$22.05 /

-2.69 (-10.87%)

RIOT Riot Blockchain
$15.00 /

-2.485 (-14.22%)

BTBT Bit Digital
$4.65 /

-0.5 (-9.71%)

BTC Bitcoin
/

+

01/14/22 BTIG
BTIG 'incrementally more positive' on Riot Blockchain after CEO chat
01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
$BTC Bitcoin
/

+

01/14/22 BTIG
BTIG 'incrementally more positive' on Riot Blockchain after CEO chat
01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
COIN Coinbase
$192.00 /

-29.5 (-13.32%)

01/19/22 Citi
Coinbase price target lowered to $300 from $415 at Citi
01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
01/06/22 BofA
Coinbase upgraded to Buy at BofA on revenue diversification
MARA Marathon Digital
$22.05 /

-2.69 (-10.87%)

01/18/22 BTIG
Marathon Digital initiated with a Buy at BTIG
01/05/22 B. Riley
Marathon Digital price target lowered to $74 from $92 at B. Riley
12/29/21 DA Davidson
DA Davidson names Marathon Digital top pick among crypto miners
11/11/21 B. Riley
Marathon Digital price target raised to $92 from $87 at B. Riley
RIOT Riot Blockchain
$15.00 /

-2.485 (-14.22%)

01/14/22 BTIG
BTIG 'incrementally more positive' on Riot Blockchain after CEO chat
01/13/22 Northland
Riot Blockchain initiated with an Outperform at Northland
01/13/22 Northland
Riot Blockchain initiated with an Outperform at Northland
01/11/22 DA Davidson
Riot Blockchain gross margin still 'quite healthy', says DA Davidson
BTBT Bit Digital
$4.65 /

-0.5 (-9.71%)

09/23/21 H.C. Wainwright
Bit Digital initiated with a Buy at H.C. Wainwright
BTC Bitcoin
/

+

$BTC Bitcoin
/

+

COIN Coinbase
$192.00 /

-29.5 (-13.32%)

MARA Marathon Digital
$22.05 /

-2.69 (-10.87%)

RIOT Riot Blockchain
$15.00 /

-2.485 (-14.22%)

BTBT Bit Digital
$4.65 /

-0.5 (-9.71%)

  • 14
    Apr
BTC Bitcoin
/

+

$BTC Bitcoin
/

+

COIN Coinbase
$192.00 /

-29.5 (-13.32%)

MARA Marathon Digital
$22.05 /

-2.69 (-10.87%)

RIOT Riot Blockchain
$15.00 /

-2.485 (-14.22%)

BTBT Bit Digital
$4.65 /

-0.5 (-9.71%)

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

COIN Coinbase
$192.00 /

-29.5 (-13.32%)

MARA Marathon Digital
$22.05 /

-2.69 (-10.87%)

RIOT Riot Blockchain
$15.00 /

-2.485 (-14.22%)

BTBT Bit Digital
$4.65 /

-0.5 (-9.71%)

COIN Coinbase
$192.00 /

-29.5 (-13.32%)

MARA Marathon Digital
$22.05 /

-2.69 (-10.87%)

RIOT Riot Blockchain
$15.00 /

-2.485 (-14.22%)

BTBT Bit Digital
$4.65 /

-0.5 (-9.71%)

Hot Stocks
Bowman Consulting acquires Perry Engineering, terms not disclosed » 07:41
01/24/22
01/24
07:41
01/24/22
07:41
BWMN

Bowman Consulting

$20.00 /

-0.45 (-2.20%)

Bowman Consulting Group …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BWMN Bowman Consulting
$20.00 /

-0.45 (-2.20%)

BWMN Bowman Consulting
$20.00 /

-0.45 (-2.20%)

01/06/22 DA Davidson
Bowman Consulting price target raised to $26 from $23 at DA Davidson
01/04/22 B. Riley
Bowman Consulting price target raised to $25 from $22 at B. Riley
11/12/21 B. Riley
Bowman Consulting price target raised to $22 from $19 at B. Riley
09/27/21 B. Riley
Bowman 'ideally positioned' to benefit from macro trends, says B. Riley
  • 07
    May
BWMN Bowman Consulting
$20.00 /

-0.45 (-2.20%)

Hot Stocks
Kohl's shares surge 27% premarket as Acacia, Sycamore show takeover interest  07:40
01/24/22
01/24
07:40
01/24/22
07:40
KSS

Kohl's

$46.83 /

-1.24 (-2.58%)

, ACTG

Acacia Research

$4.34 /

-0.03 (-0.69%)

 
ShowHide Related Items >><<
KSS Kohl's
$46.83 /

-1.24 (-2.58%)

ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

06:54 Today Credit Suisse
Kohl's take-out offer has some merit, says Credit Suisse
06:16 Today Citi
Kohl's 'mispriced,' so reasonable to consider offers, says Citi
01/07/22 UBS
Kohl's downgraded to Sell from Neutral at UBS
01/04/22 JPMorgan
Kohl's price target lowered to $55 from $73 at JPMorgan
ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

06:54 Today Credit Suisse
Kohl's take-out offer has some merit, says Credit Suisse
KSS Kohl's
$46.83 /

-1.24 (-2.58%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

Downgrade
Pilbara Minerals downgraded to Hold from Buy at Canaccord » 07:40
01/24/22
01/24
07:40
01/24/22
07:40
PILBF

Pilbara Minerals

$2.49 /

-0.286 (-10.31%)

Canaccord analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PILBF Pilbara Minerals
$2.49 /

-0.286 (-10.31%)

09/15/21 Canaccord
Pilbara Minerals upgraded to Buy from Hold at Canaccord
08/27/21 JPMorgan
Pilbara Minerals downgraded to Neutral from Overweight at JPMorgan
08/12/21 Canaccord
Pilbara Minerals downgraded to Hold from Buy at Canaccord
08/10/21 JPMorgan
Pilbara Minerals upgraded to Overweight from Neutral at JPMorgan
Periodicals
Kohl's suitors include Sycamore, willing to pay at least $65/share, CNBC says » 07:39
01/24/22
01/24
07:39
01/24/22
07:39
KSS

Kohl's

$46.83 /

-1.24 (-2.58%)

, ACTG

Acacia Research

$4.34 /

-0.03 (-0.69%)

Kohl's (KSS) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KSS Kohl's
$46.83 /

-1.24 (-2.58%)

ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

06:54 Today Credit Suisse
Kohl's take-out offer has some merit, says Credit Suisse
06:16 Today Citi
Kohl's 'mispriced,' so reasonable to consider offers, says Citi
01/07/22 UBS
Kohl's downgraded to Sell from Neutral at UBS
01/04/22 JPMorgan
Kohl's price target lowered to $55 from $73 at JPMorgan
ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

06:54 Today Credit Suisse
Kohl's take-out offer has some merit, says Credit Suisse
KSS Kohl's
$46.83 /

-1.24 (-2.58%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

ACTG Acacia Research
$4.34 /

-0.03 (-0.69%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

Hot Stocks
Mandalay Resources provides update on drilling programs at Bjorkdal » 07:39
01/24/22
01/24
07:39
01/24/22
07:39
MNDJF

Mandalay Resources

$1.92 /

-0.05 (-2.54%)

Mandalay Resources…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNDJF Mandalay Resources
$1.92 /

-0.05 (-2.54%)

01/14/22 BMO Capital
Mandalay Resources price target lowered to C$4.50 from C$5 at BMO Capital
Downgrade
Ioneer downgraded to Hold from Speculative Buy at Canaccord » 07:37
01/24/22
01/24
07:37
01/24/22
07:37
GSCCF

Ioneer

/

+

Canaccord analyst Tim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Camping World adds $152,708,900 to existing stock repurchase program » 07:37
01/24/22
01/24
07:37
01/24/22
07:37
CWH

Camping World

$31.26 /

-1.405 (-4.30%)

Camping World Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CWH Camping World
$31.26 /

-1.405 (-4.30%)

CWH Camping World
$31.26 /

-1.405 (-4.30%)

11/04/21 Raymond James
Camping World price target raised to $54 from $47 at Raymond James
08/04/21
Fly Intel: Top five analyst upgrades
08/04/21 Baird
Camping World upgraded to Outperform on 'healthy' demand at Baird
08/04/21 Baird
Camping World upgraded to Outperform from Neutral at Baird
CWH Camping World
$31.26 /

-1.405 (-4.30%)

CWH Camping World
$31.26 /

-1.405 (-4.30%)

CWH Camping World
$31.26 /

-1.405 (-4.30%)

Initiation
Vext Science initiated with a Speculative Buy at Canaccord » 07:37
01/24/22
01/24
07:37
01/24/22
07:37
VEXTF

Vext Science

/

+

Canaccord Genity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Arbutus Biopharma sees cash funding operations into Q2 of 2024 » 07:36
01/24/22
01/24
07:36
01/24/22
07:36
ABUS

Arbutus Biopharma

$2.69 /

-0.12 (-4.27%)

"We believe our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

12/29/21 Jefferies
Arbutus Biopharma assumed with a Hold at Jefferies
12/13/21 H.C. Wainwright
H.C. Wainwright sees Arbutus' $300M-plus licensing deal for AB-729 as low-risk
12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
12/02/21 Chardan
Arbutus Biopharma price target raised to $5.50 from $5 at Chardan
ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

Hot Stocks
Arbutus Biopharma announces 2022 corporate objectives, financial update » 07:36
01/24/22
01/24
07:36
01/24/22
07:36
ABUS

Arbutus Biopharma

$2.69 /

-0.12 (-4.27%)

Arbutus Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

12/29/21 Jefferies
Arbutus Biopharma assumed with a Hold at Jefferies
12/13/21 H.C. Wainwright
H.C. Wainwright sees Arbutus' $300M-plus licensing deal for AB-729 as low-risk
12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
12/02/21 Chardan
Arbutus Biopharma price target raised to $5.50 from $5 at Chardan
ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

ABUS Arbutus Biopharma
$2.69 /

-0.12 (-4.27%)

Recommendations
Wedbush expects another robust performance from Microsoft in December quarter » 07:35
01/24/22
01/24
07:35
01/24/22
07:35
MSFT

Microsoft

/

+

, ATVI

Activision Blizzard

$81.36 /

-0.43 (-0.53%)

Ahead of quarterly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
/

+

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

MSFT Microsoft
/

+

01/20/22 Morgan Stanley
Sony named a 'Research Tactical Idea' at Morgan Stanley
01/20/22 BMO Capital
Activision Blizzard price target raised to $95 from $90 at BMO Capital
01/20/22 Citi
Microsoft price target lowered to $376 from $407 at Citi
01/19/22 BTIG
Zynga downgraded to Neutral from Buy at BTIG
ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

01/20/22 Morgan Stanley
Sony named a 'Research Tactical Idea' at Morgan Stanley
01/20/22 BMO Capital
Activision Blizzard price target raised to $95 from $90 at BMO Capital
01/19/22 BTIG
Zynga downgraded to Neutral from Buy at BTIG
01/19/22 RBC Capital
RBC Capital positive on Microsoft acquisition of Activision Blizzard
MSFT Microsoft
/

+

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

MSFT Microsoft
/

+

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

MSFT Microsoft
/

+

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

MSFT Microsoft
/

+

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

Recommendations
William Blair sees 'compelling' entry points for two healthcare tech names » 07:35
01/24/22
01/24
07:35
01/24/22
07:35
OPRX

OptimizeRx

$42.00 /

-1.805 (-4.12%)

, DOCS

Doximity

$43.42 /

-0.99 (-2.23%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPRX OptimizeRx
$42.00 /

-1.805 (-4.12%)

DOCS Doximity
$43.42 /

-0.99 (-2.23%)

OPRX OptimizeRx
$42.00 /

-1.805 (-4.12%)

12/27/21 B. Riley
B. Riley recommends LifeMD, OptimizeRx, Semler, Zynex into 2022
11/10/21 Roth Capital
OptimizeRx price target raised to $112 from $85 at Roth Capital
10/18/21 B. Riley
OptimizeRx resumed with a Buy at B. Riley
08/05/21 B. Riley
OptimizeRx price target raised to $95 from $80 at B. Riley
DOCS Doximity
$43.42 /

-0.99 (-2.23%)

12/14/21 JPMorgan
Doximity downgraded to Underweight from Neutral at JPMorgan
12/14/21 JPMorgan
Doximity downgraded to Underweight from Neutral at JPMorgan
12/01/21 Jefferies
Doximity initiated with a Buy at Jefferies
11/16/21 Baird
Baird starts 'unique asset' Doximity with Outperform, $84 target
OPRX OptimizeRx
$42.00 /

-1.805 (-4.12%)

DOCS Doximity
$43.42 /

-0.99 (-2.23%)

  • 24
    Jun
  • 09
    Feb
DOCS Doximity
$43.42 /

-0.99 (-2.23%)

OPRX OptimizeRx
$42.00 /

-1.805 (-4.12%)

DOCS Doximity
$43.42 /

-0.99 (-2.23%)

DOCS Doximity
$43.42 /

-0.99 (-2.23%)

Hot Stocks
Oral argument for Worlds Inc. appeal in Activision case set for March 8 » 07:35
01/24/22
01/24
07:35
01/24/22
07:35
WDDD

Worlds Inc.

/

+

, ATVI

Activision Blizzard

$81.36 /

-0.43 (-0.53%)

The U.S. Court of Appeals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDDD Worlds Inc.
/

+

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

WDDD Worlds Inc.
/

+

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

01/20/22 Morgan Stanley
Sony named a 'Research Tactical Idea' at Morgan Stanley
01/20/22 BMO Capital
Activision Blizzard price target raised to $95 from $90 at BMO Capital
01/19/22 BTIG
Zynga downgraded to Neutral from Buy at BTIG
01/19/22 RBC Capital
RBC Capital positive on Microsoft acquisition of Activision Blizzard
ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

ATVI Activision Blizzard
$81.36 /

-0.43 (-0.53%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.